Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve Audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals Ltd has informed BSE that its Board of Directors will meet on Wednesday, 28 May 2025 at 3:00 PM at the Corporate Office in Chembur, Mumbai. The main agenda is to approve the Standalone Audited Financial Results for the quarter and financial year ended 31 March 2025. The Board will also consider and recommend a Final Dividend, if any, for FY 2024-25. Additionally, any other matter may be taken up with the Chairman's permission. The trading window for directors, officers, and designated employees has been closed from 1 April 2025 and will remain shut until 48 hours after the results are publicly announced.
This is a routine pre-results announcement and does not change the stock's fundamentals on its own. Investors should watch for the actual audited numbers and any dividend declaration on 28 May 2025, which could influence the stock price and shareholder returns.